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Abstract  
Objective: to determine the frequency of Kell-1 and Kell-2 and their gene frequencies in the Sudanese population. 
Design: This study was carried out on 500 samples in five major Sudanese tribes. Each sample was tested for Kell-1 and 
Kell-2 by indirect coombs’ test using anti Kell-1 and Kell-2 antisera. 
Setting: AL-Neelain University – College of Medical Laboratory Sciences – Sudan – Khartoum. 
Results: The frequency of Kell-1among the tribes was found to be 5.6% while that of Kell-2 was found to be 99.6%.  Gene 
frequencies of Kell-1 and Kell-2 were found to be 0.03 and 0.97 respectively. 
Conclusions: The frequency of Kell-1 is 5.6% and its gene frequency is 0.03 while the positivity of Kell-2 is 99.6% and its 
gene frequency is 0.97.  
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INTRODUCTION 
 
     Kell glycoprotein appears on erythroid progenitor cells at an 
early stage of erythropoiesis(1). 
     Kell is one of the major blood group systems on human 
erythrocytes. It is a complex system containing large number of 
antigens(2) . Coombs et al(3) and Race(4) reported the first case of 
anti-K in 1946 while Levine et al(5) discovered anti-K three years later. 
Presently 21 antigens are accepted to be associated with this system 
of blood group in Man. Kell-1 (K) which is present in 9% of the 
population of U.S.A. is antithetical to the high prevalence Kell-2 (k) 
antigen(6). Besides these 21 antigens, two other antigens TOU(7) and 
RAZ(8) are believed to belong to this blood group system. Kell gene is 
carried on chromosome 7 and is located at 7q33. Kell transcripts are 
only present in fetal liver and bone marrow(9). 
     Antibodies of Kell blood group system are immune in nature 
and belong to the IgG class of immunoglobulins. Theses antibodies 
can cause severe reactions if incompatible blood is transfused. They 
may also cause haemolytic disease of the newborn. Determination of 
Kell-1 and Kell-2 genotype using DNA-based method provides 
accurate and timely information that can aid the prenatal care of 
women sensitized to Kell antigens(10). 
 
MATERIAL AND METHODS 
 
     This study was carried out on 500 random samples collected 
from different laboratories and blood banks in Khartoum Sudan. 
Each sample was tested for Kell-1 and Kell-2 antigens by indirect 
coombs’test. Red cells were washed with normal saline three times 
and 5% suspension was prepared. One drop each of anti-Kell-1 or 
anti-Kell-2 was added to three drops of cell suspension and 
incubated at 37oC for 30 minutes. After incubation the suspension 
was washed with normal saline three times. One drop of coombs’ 
reagent was added and incubated at 37oC for one minute and 
observed for agglutination macroscopically  and microscopically. A 
batch of  20 samples was run at a time, positive and negative 
controls were run with each batch. 
 
RESULTS 
 
     Frequency for Kell-1 in Sudanese population is found to be 
5.6% the gene frequency being 0.03. percent positivity for Kell-2 is 
99.6% and the gene frequency is 0.97. positivity for KK genotype is 
0.4 % and its frequency is 0.0009. Percent positivity for  Kk is found 
to be 5.2% and its gene frequency being 0.058. Percent positivity for 
kk is determined as 94.4% and its gene frequency is 0.941. K null 
genotype was encountered in 1.53% of the samples with the gene 
frequency of 0.00052. 
 
DISCUSSION 
 
           Percent positivity for Kell-1 in the Sudanese population lies 
some where between the values found in the American(blacks) and 
Algeria. Among the studies carried out in other countries, Kell-1 has 
demonstrated its highest incidence in the Arabs i.e. 25% and least in 
the Japanese i.e., 0.0001. 
           Percent positivity for Kell-2 in the Sudanese population was 
compared with that in the English population and the study shows no 
significant difference in the values from these two racially diverse 
populations. Similar studies from other countries have not been 
reported. 
           Antibodies in the Kell blood group system are always immune 
antibodies of IgG type; no naturally occurring antibodies have so far 
been reported. These are produced as a result of pregnancy or 
repeated blood transfusions. This implies that the population at risk 
of developing Kell associated immune hemolysis comprises of 
patients who are obliged to receive repeated blood transfusions i.e., 
patients with aplastic anemias, congenital hemolytic anemias and 
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acquired hemolytic anemias of immunological and non-
immunological origin. The other group of individual to produce 
immune antibodies is women who conceive; the incidence of Kell 
sensitization increasing with each Kell –incompatible pregnancy. 
          Since hemolytic transfusion reactions due to Kell 
incompatibility are of significant magnitude and the hemolytic 
disease in the babies born to Kell sensitized mothers can be of 
serious import, it is suggested that: 
a. Multiple transfused patients must be screened for the presence 
of anti-Kell antibodies. Presence of these antibodies shall make 
it mandatory to genotype all prospective donors selected for 
these patients; only those donors are to be accepted who lack 
the corresponding Kell antigen. 
b. In women with the history of multiple pregnancies, repeated 
miscarriages and hemolytic disease of the newborn not due to 
feto-maternal Rh incompatibility, Kell blood group mismatch 
must be considered as a likely cause of these episodes. 
c. prior screening for anti-Kell antibodies of the Kell negative 
expectant mothers is mandatory for timely intervention in the 
event that the newborn manifests hemolytic disease. Under 
these circumstances it will be mandatory to use Kell negative 
blood for exchange transfusion. 
d. Genotyping for Kell genes and screening for anti Kell antibodies 
in the general population is not recommended for two reasons; 
firstly the antibodies are always immune and only those 
individuals who receive repeated blood transfusions or multi-
gravida with the history of HDNB are at risk of developing them. 
Secondly Kell-1 gene is a comparatively low frequency gene , 
hence chances of a Kell-1 negative person receiving Kell-1 
positive blood are relatively small. Also the cost of routine 
screening does not justify the expected benefits. It is therefore 
recommended that: 
 
I. All multigravida females with a history of  HDNB should be 
screened for anti Kell antibodies. 
II. All multitransfused patients should be screened for anti Kell 
antibodies. 
III. All units of blood to be transfused to Kell-1 sensitized 
patients must be Kell genotyped. 
 
           These recommendations shall ensure effective prevention of 
Kell associated hemolytic reactions at an acceptable expense and 
render Kell genotype and screen practicable and cost effective. 
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